Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41642,226,1.05 [0.81-1.36],0.7198969314533448
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43076,323,1.14 [0.94-1.38],0.1753814542453208
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42641,2260,0.93 [0.85-1.02],0.1237510262124846
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43107,697,1.04 [0.90-1.21],0.5662837136828718
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,41796,5745,0.98 [0.93-1.04],0.503144568692493
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42001,5230,0.98 [0.93-1.04],0.4763325143346715
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42697,1995,0.99 [0.91-1.09],0.8649566773537871
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,42960,142,1.12 [0.83-1.51],0.4495331608140334
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39755,1551,1.04 [0.95-1.15],0.3915629495995332
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38386,1738,0.96 [0.87-1.06],0.4146900806621928
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38247,406,0.93 [0.75-1.15],0.4983806233329182
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30235,3204,0.99 [0.92-1.06],0.7864173297360437
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38007,641,0.98 [0.84-1.16],0.8374248830567087
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43048,2346,1.02 [0.94-1.10],0.676097669254967
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,43230,820,1.01 [0.88-1.16],0.8507324375588722
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41890,1509,0.99 [0.90-1.10],0.8960114920099693
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43123,1707,1.05 [0.96-1.15],0.2792275104108551
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41027,325,1.13 [0.93-1.37],0.2115937319832423
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43321,77,0.53 [0.28-1.01],0.0544406247448301
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42913,1497,1.06 [0.96-1.17],0.276297567677081
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42943,125,1.19 [0.89-1.60],0.248530853846378
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43180,260,1.03 [0.82-1.31],0.777936294170807
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43152,232,1.01 [0.78-1.30],0.9495145419781564
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41053,672,0.88 [0.74-1.04],0.1349267710034789
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,40838,457,0.85 [0.69-1.06],0.1441875845297284
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,40871,169,0.96 [0.70-1.32],0.8161999544247674
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43280,88,0.87 [0.54-1.41],0.5818110647180539
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43206,263,1.04 [0.82-1.32],0.7492750260471807
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,43028,85,1.03 [0.68-1.57],0.8876193040776736
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43058,115,1.07 [0.75-1.51],0.7135934173435303
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,42819,489,1.08 [0.91-1.27],0.390594421206743
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43171,98,1.15 [0.81-1.62],0.4421898564109722
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43132,107,1.11 [0.79-1.57],0.54942996969695
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19825,107,1.12 [0.78-1.59],0.5426581519370393
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42757,2391,0.98 [0.90-1.07],0.6955490044905196
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of meninges,43296,99,1.09 [0.76-1.57],0.6384852496161045
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43213,114,0.94 [0.63-1.39],0.7494789654479769
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43278,179,0.91 [0.66-1.26],0.5742743672985582
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.36 [1.09-1.69],0.0063496232306652
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43279,610,0.88 [0.73-1.05],0.1657680479509691
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,43288,499,0.98 [0.82-1.18],0.8550984381628259
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43132,118,1.15 [0.84-1.58],0.3868600081115206
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43282,371,0.85 [0.67-1.07],0.1684060502799331
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,43206,584,0.89 [0.74-1.07],0.210376936679925
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43118,1044,1.09 [0.98-1.23],0.1224959506781329
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43272,704,0.89 [0.76-1.06],0.1868355160217335
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,1.17 [0.87-1.58],0.3033165149179083
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.99 [0.71-1.39],0.9704151563051864
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34555,92,0.35 [0.18-0.67],0.0013490070731914
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34577,114,0.98 [0.67-1.43],0.9254636720707744
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43233,202,0.94 [0.70-1.26],0.6923163463746413
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",43234,197,0.96 [0.71-1.28],0.763664128791277
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,0.85 [0.70-1.04],0.1080961775044252
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,30092,568,1.12 [0.98-1.29],0.1073176146140418
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lymphoid leukaemia,34552,89,0.56 [0.31-1.01],0.0553829176144575
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34776,313,0.80 [0.61-1.04],0.0968896253338289
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34795,332,1.04 [0.85-1.29],0.6838831405917137
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.20 [0.93-1.54],0.1673928433144527
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34599,136,0.79 [0.52-1.19],0.2517206545272585
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34630,167,0.97 [0.70-1.33],0.838703219671002
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34633,170,1.17 [0.90-1.52],0.2314346436055631
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,1.18 [0.88-1.59],0.2662595953596628
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34622,159,1.15 [0.88-1.51],0.2967299097065656
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16567,1143,0.82 [0.71-0.94],0.0056774316794785
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34661,198,1.15 [0.90-1.46],0.266507721094862
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34586,123,0.98 [0.68-1.42],0.9325493982984716
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34635,172,0.93 [0.68-1.28],0.6643363527608742
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,42996,349,0.93 [0.74-1.16],0.5103237307065215
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,43259,154,0.79 [0.54-1.15],0.2171544046327392
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanoma in situ,34518,137,0.57 [0.36-0.92],0.0208091245032952
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34617,154,0.84 [0.58-1.22],0.3660588829335073
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34731,268,0.77 [0.58-1.04],0.0858175215910554
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",34856,393,1.10 [0.92-1.32],0.3038231184550055
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34629,166,0.98 [0.72-1.35],0.9237152025199952
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,43017,272,1.15 [0.93-1.41],0.1952785477389607
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36238,1775,0.99 [0.90-1.09],0.7983342622962243
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36334,1871,0.98 [0.89-1.08],0.6840031423827072
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42820,573,1.19 [1.04-1.37],0.0127247912036999
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40220,146,0.87 [0.60-1.26],0.468643093557833
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42372,125,0.96 [0.66-1.39],0.8243640843266039
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42023,4768,1.05 [0.99-1.11],0.1114404103961054
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,40940,78,0.71 [0.40-1.26],0.241522577063772
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42632,85,0.85 [0.52-1.40],0.532147342898631
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42546,2472,1.07 [0.99-1.15],0.0688415063190425
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42544,2470,1.07 [1.00-1.16],0.066162342606514
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40217,143,1.05 [0.76-1.44],0.7655257544386406
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42786,1924,0.98 [0.90-1.08],0.7122877877386959
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42737,190,1.05 [0.80-1.39],0.7013994096995417
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42350,103,1.05 [0.72-1.53],0.7958589789927537
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42354,107,0.80 [0.51-1.27],0.3450352178897538
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,42998,451,1.02 [0.84-1.22],0.8733880203682769
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43145,91,0.94 [0.61-1.45],0.776136471190563
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",42922,375,1.05 [0.87-1.28],0.6064959205641867
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41033,171,1.00 [0.74-1.35],0.9823071065391892
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33618,504,1.08 [0.91-1.28],0.3802942790934394
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40395,191,1.02 [0.77-1.34],0.9119011318635908
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40415,211,1.05 [0.80-1.38],0.7192732955874013
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33205,91,1.31 [0.95-1.80],0.0980119705703635
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40273,106,1.05 [0.73-1.51],0.804813727665252
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39354,387,0.96 [0.77-1.18],0.6740284404845374
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42568,876,0.98 [0.85-1.12],0.7373775459251053
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42136,444,0.78 [0.62-0.98],0.0340037280746991
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,41864,172,0.88 [0.62-1.23],0.4459924245561013
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42747,2580,0.97 [0.90-1.05],0.4757717127170926
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,37829,2511,0.98 [0.91-1.06],0.6371789937010865
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33222,108,1.22 [0.88-1.68],0.2355939949725639
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40025,137,0.98 [0.69-1.38],0.9077602892823488
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33575,461,0.94 [0.77-1.15],0.5679295856520286
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33216,102,1.22 [0.87-1.70],0.2512183131582121
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,38997,5883,0.99 [0.93-1.04],0.6050480781864198
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33447,333,0.94 [0.74-1.18],0.5785525425847357
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34041,927,0.99 [0.86-1.13],0.8612127335852783
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43193,524,0.94 [0.79-1.13],0.5390550951864813
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,42878,209,1.11 [0.87-1.42],0.3906969251003865
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33327,213,1.02 [0.78-1.34],0.8788898479789596
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33216,102,0.81 [0.51-1.29],0.3717540698289902
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42423,2535,1.07 [0.99-1.15],0.0856214536246502
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33521,407,1.07 [0.88-1.29],0.50274861865614
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33560,446,0.88 [0.71-1.09],0.2447478552152037
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34167,1053,1.11 [0.99-1.25],0.0612826382856743
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33295,181,1.15 [0.88-1.51],0.2902560551048799
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,42867,198,1.07 [0.82-1.39],0.6327246694369548
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34115,1001,1.12 [1.00-1.25],0.0548142917643485
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,33912,798,0.96 [0.82-1.11],0.5528835935631373
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39074,107,1.14 [0.81-1.60],0.4426474985060681
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41424,8310,1.00 [0.96-1.04],0.9432983043800328
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,39961,73,0.42 [0.21-0.84],0.0141183834498883
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,39985,97,1.43 [1.11-1.86],0.0065414583036158
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43022,3209,0.99 [0.92-1.06],0.700656605040427
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43022,3203,0.99 [0.92-1.06],0.7523355086505665
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,39970,82,0.99 [0.64-1.54],0.9791643305617376
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42743,2022,1.06 [0.98-1.15],0.1528483076461472
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35700,2586,1.05 [0.97-1.13],0.2333627475553493
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43304,347,0.89 [0.70-1.13],0.3531766647714789
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,41815,123,0.99 [0.68-1.43],0.9436758621096552
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,40898,177,0.95 [0.69-1.30],0.7381061143706044
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,40963,242,0.95 [0.73-1.24],0.7092483780763464
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33382,268,0.95 [0.74-1.22],0.6827475703761051
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39436,255,0.96 [0.74-1.24],0.7461940801465852
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3553,138,1.14 [0.81-1.60],0.4635096227988572
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3783,414,0.96 [0.76-1.20],0.707804488262505
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39283,102,1.21 [0.87-1.69],0.2612849536910095
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3492,78,0.93 [0.54-1.60],0.7855035156520112
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42287,3106,0.92 [0.85-1.00],0.0413200553695374
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42243,551,0.98 [0.82-1.17],0.8038208437812953
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39574,607,1.05 [0.90-1.23],0.5358893963979608
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34339,1225,0.97 [0.86-1.09],0.6150852534197959
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43126,407,0.88 [0.71-1.10],0.269644707850036
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41441,276,1.09 [0.87-1.37],0.4568765224253096
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,39633,1952,0.99 [0.90-1.09],0.8583663459651479
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41572,407,1.00 [0.82-1.23],0.9634969293589624
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41260,95,1.22 [0.87-1.71],0.243948033679493
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41491,326,0.96 [0.76-1.22],0.7518582276349608
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26873,3107,1.01 [0.95-1.09],0.7032166916484442
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,AV-block,36646,703,0.98 [0.84-1.15],0.8032058078692424
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43220,689,0.88 [0.74-1.04],0.1283754643680234
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24077,311,1.22 [1.01-1.47],0.0407889066797048
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36228,285,0.75 [0.56-1.00],0.0521391326453929
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36104,161,0.89 [0.63-1.26],0.5012642898938067
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43319,74,0.98 [0.61-1.58],0.9249591472867418
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,37673,1730,1.04 [0.95-1.14],0.3826183459704583
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41082,3429,0.98 [0.92-1.05],0.6165638892225027
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,37920,12700,0.99 [0.96-1.03],0.750311270534043
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41027,439,0.92 [0.75-1.13],0.4430500394588097
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Endocarditis,36058,115,0.80 [0.51-1.25],0.3244007325564307
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42976,1787,0.96 [0.87-1.06],0.3819284181254163
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,39439,10868,1.00 [0.96-1.04],0.9699562095609924
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39453,10882,1.00 [0.96-1.04],0.9271873117320076
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43034,131,1.02 [0.72-1.44],0.9184692468234292
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28883,312,0.94 [0.73-1.20],0.6181593529727671
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28728,157,1.02 [0.74-1.42],0.9000284220400445
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,43087,1878,0.92 [0.83-1.02],0.0978777441900586
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,41818,176,0.93 [0.68-1.29],0.67111279632399
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41366,3685,1.01 [0.94-1.08],0.8159115339997904
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42720,921,0.99 [0.87-1.13],0.8862293853401044
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36547,604,1.07 [0.91-1.24],0.4106447494445071
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42549,1402,1.00 [0.89-1.11],0.9358518788893304
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38862,1181,1.04 [0.93-1.17],0.4479137265239334
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43161,263,1.03 [0.81-1.31],0.8230833758672121
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43270,525,1.07 [0.91-1.26],0.4354202015482781
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,40677,89,0.51 [0.28-0.93],0.0290008070507808
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,41286,121,0.86 [0.56-1.30],0.4600589377964733
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,36651,708,0.86 [0.73-1.02],0.0878037875040378
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41333,168,1.05 [0.77-1.41],0.7701588099830481
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41563,398,1.09 [0.91-1.32],0.3358204143032183
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36239,296,1.03 [0.83-1.29],0.7637724556637467
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,40735,147,1.07 [0.79-1.45],0.6685685481402925
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40670,82,1.12 [0.76-1.65],0.5597212684275694
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,40973,107,1.05 [0.72-1.53],0.7884629508609735
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,40804,216,1.00 [0.76-1.30],0.9831533750599766
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37626,1683,0.94 [0.85-1.04],0.2340731015701843
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41299,90,0.73 [0.43-1.24],0.246627179946773
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42061,896,1.13 [1.00-1.27],0.0480720836494951
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42286,585,0.93 [0.77-1.11],0.3955401285715979
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",41859,993,0.83 [0.72-0.96],0.0148825691963084
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24319,553,0.97 [0.81-1.15],0.7017098370262613
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41773,658,1.12 [0.98-1.29],0.1024349881260484
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41157,569,0.92 [0.77-1.10],0.3664689723300008
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42484,783,1.02 [0.88-1.17],0.7997631714566673
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43199,1067,1.01 [0.89-1.14],0.891431117928079
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36517,574,1.11 [0.96-1.29],0.1642843574044921
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42279,578,0.93 [0.78-1.11],0.4245718415841685
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41175,309,0.85 [0.66-1.10],0.2223819852054405
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42698,1056,0.98 [0.86-1.11],0.7497126535378067
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42665,1121,1.00 [0.88-1.12],0.9627180305960222
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41776,100,1.06 [0.73-1.54],0.7478748448278996
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41296,132,0.93 [0.64-1.35],0.7022117654112108
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42170,371,1.08 [0.89-1.31],0.4180352595766822
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41578,431,0.78 [0.62-0.99],0.040290850529267
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,41274,686,0.95 [0.82-1.12],0.5629489416770803
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41191,143,0.98 [0.70-1.39],0.9307497857483468
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42928,1232,0.99 [0.88-1.11],0.8058293431495631
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43112,597,0.99 [0.84-1.17],0.930630799663461
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",37982,2390,1.03 [0.95-1.11],0.4996083871623259
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,42235,6643,0.99 [0.95-1.04],0.8029778328033714
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43033,698,1.00 [0.85-1.16],0.9500674876205272
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38223,2631,0.98 [0.91-1.06],0.6238220377803545
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35733,141,0.87 [0.60-1.26],0.4702664103805347
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,42422,2302,1.02 [0.94-1.11],0.5906506881810691
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38317,2725,1.02 [0.95-1.10],0.5584859812507524
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Vascular dementia,42529,209,0.80 [0.58-1.12],0.1934712879716659
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,43319,555,0.88 [0.73-1.06],0.1820543601949216
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29374,97,0.57 [0.32-1.01],0.053217821209434
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Bell's palsy,40356,139,1.12 [0.83-1.51],0.4676186194482761
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41045,828,0.99 [0.86-1.13],0.8318002285056072
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,42645,382,1.05 [0.86-1.27],0.6316558418403614
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43183,504,0.91 [0.75-1.10],0.3363557528750845
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42509,91,0.73 [0.43-1.23],0.2365546140854938
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43293,109,0.95 [0.64-1.42],0.8021786463459006
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42384,121,1.15 [0.84-1.57],0.3906610800080408
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,40751,464,0.93 [0.77-1.13],0.4718688683872478
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42523,2236,0.99 [0.91-1.07],0.7455830602401607
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43244,692,1.00 [0.86-1.16],0.9785473728426104
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42329,4209,0.99 [0.94-1.06],0.8624643494491621
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,42698,88,0.77 [0.46-1.29],0.3236445322925501
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,43075,396,0.90 [0.72-1.12],0.3606184301144947
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,42367,104,1.14 [0.81-1.61],0.4383455403862477
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43286,116,1.02 [0.72-1.47],0.8927910295000094
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40343,126,0.99 [0.70-1.40],0.9436455108663886
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40351,134,1.10 [0.80-1.50],0.5630535780912042
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Memory loss,42288,194,0.81 [0.58-1.14],0.2280196237415585
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,40881,594,0.80 [0.66-0.97],0.020689367751879
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43203,539,0.73 [0.59-0.90],0.0031953525237157
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,29562,249,0.86 [0.65-1.14],0.3013096909782149
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43029,178,0.96 [0.71-1.30],0.7780415655553434
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42208,1991,0.98 [0.89-1.07],0.6295709190831957
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,40832,6070,0.96 [0.91-1.02],0.1688307758918528
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42721,303,0.94 [0.73-1.20],0.6018911582283744
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40882,665,0.96 [0.82-1.12],0.5892542208637741
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43198,483,1.01 [0.84-1.21],0.9305685298117968
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34668,1062,0.91 [0.80-1.04],0.1619551034352441
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42383,120,0.60 [0.36-0.98],0.0413221884292505
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42494,231,0.71 [0.51-1.00],0.0467461476983701
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,42800,248,0.98 [0.75-1.26],0.8523262129874979
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40381,164,1.02 [0.75-1.38],0.9050747703817268
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,40389,102,1.27 [0.95-1.71],0.1113830320988395
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,43120,857,0.98 [0.85-1.12],0.7577997957946225
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,41201,914,1.08 [0.96-1.22],0.2211573591748557
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,43276,405,1.04 [0.85-1.26],0.7083870668003822
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42356,93,1.00 [0.67-1.50],0.9957686834264448
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43317,110,0.92 [0.61-1.38],0.6721189050624063
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,42928,796,1.08 [0.95-1.23],0.2598650819786932
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,42795,80,0.92 [0.57-1.50],0.7453081611677502
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43292,293,0.92 [0.72-1.18],0.5141685070193484
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40302,85,0.89 [0.55-1.42],0.6181406652789667
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43319,561,0.88 [0.73-1.06],0.1886192778493717
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42463,202,0.83 [0.60-1.16],0.2797458885333608
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42364,160,0.97 [0.70-1.35],0.873045302654406
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42642,663,0.97 [0.83-1.14],0.736277288202888
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43045,387,0.89 [0.72-1.12],0.3309335445610053
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41634,85,1.00 [0.65-1.53],0.98740870142004
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41648,99,1.07 [0.73-1.55],0.739237413883
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43134,90,0.87 [0.54-1.39],0.5641293781345327
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,42890,250,0.73 [0.53-1.00],0.0492626493579274
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3499,84,1.02 [0.62-1.66],0.951241211745166
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4238,160,1.05 [0.75-1.46],0.7763623087329122
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42368,164,1.15 [0.88-1.50],0.3204075179622022
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,42980,1721,0.94 [0.85-1.04],0.2071178859363525
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42694,1145,1.02 [0.91-1.14],0.7734982821255307
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41922,373,0.93 [0.74-1.16],0.5023014161356754
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43183,1204,0.99 [0.89-1.12],0.9299871729267324
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43305,116,0.72 [0.46-1.15],0.173490655909823
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43068,1089,0.97 [0.85-1.09],0.5876099098348999
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43251,611,0.89 [0.75-1.07],0.2095142259090712
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43166,304,0.79 [0.60-1.04],0.0899369081728774
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41651,102,1.04 [0.71-1.52],0.8376753544901165
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41661,112,1.02 [0.70-1.48],0.92937343394532
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41644,95,0.98 [0.64-1.48],0.9078516923025004
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43168,1180,1.10 [0.99-1.22],0.0774285527258469
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42303,315,0.99 [0.79-1.25],0.954001090802026
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42054,75,1.17 [0.79-1.73],0.4417589799666549
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,42804,164,0.83 [0.58-1.19],0.3080395179103423
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43100,460,0.89 [0.72-1.09],0.2577046893751924
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42309,330,0.85 [0.66-1.09],0.1912468702667434
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43045,183,0.66 [0.45-0.97],0.0357093229784341
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42755,767,1.04 [0.90-1.19],0.6275972276633852
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42434,230,1.06 [0.83-1.36],0.6162180252458065
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40674,3641,1.00 [0.93-1.07],0.929590091337582
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43042,402,0.87 [0.69-1.08],0.2066763773188488
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43282,256,1.04 [0.82-1.32],0.7510760462972725
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42228,679,1.11 [0.97-1.27],0.1383501116082391
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,42752,112,0.85 [0.55-1.31],0.4533057427985205
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43282,93,0.77 [0.47-1.28],0.3126959536367313
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41691,142,1.00 [0.72-1.40],0.9775692395396728
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41801,252,1.12 [0.90-1.40],0.3116540345981001
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41450,191,1.06 [0.81-1.39],0.6842926984412494
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42070,91,1.28 [0.93-1.75],0.1278253129546731
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41363,104,1.02 [0.70-1.50],0.9126369599397816
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42131,143,1.33 [1.04-1.68],0.0212613413762845
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42312,324,1.07 [0.87-1.32],0.5260931297881977
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41748,199,1.12 [0.87-1.44],0.3750995927626136
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41440,181,1.01 [0.75-1.35],0.9713247420937968
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41392,133,0.81 [0.53-1.21],0.3029003224237839
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40005,2972,1.03 [0.95-1.10],0.4939856610225195
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41672,123,0.87 [0.58-1.30],0.5043875269156468
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42887,683,1.01 [0.86-1.17],0.937010722992754
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42299,95,0.99 [0.66-1.51],0.9797452405533412
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42474,270,0.99 [0.77-1.26],0.9124299843887616
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,42947,149,1.05 [0.77-1.43],0.7619712185575601
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43243,198,0.94 [0.69-1.26],0.6663519569398576
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43102,217,0.74 [0.53-1.04],0.0820442534361536
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,42904,106,1.09 [0.76-1.55],0.6395566167609665
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,42909,111,0.94 [0.63-1.40],0.7681864417982798
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43144,1444,0.95 [0.85-1.06],0.3501370867695221
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42737,1037,0.91 [0.80-1.04],0.1721292289834216
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,41907,207,0.96 [0.72-1.29],0.8034852471378793
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,41838,138,1.21 [0.92-1.59],0.1768283560031414
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,42898,121,0.95 [0.66-1.39],0.8010122788235344
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43137,360,1.02 [0.83-1.25],0.8281847930304358
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,42882,105,0.54 [0.31-0.93],0.0267262602649237
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza,40036,191,1.06 [0.80-1.39],0.6902448532518701
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40032,187,1.07 [0.81-1.40],0.6500402621895119
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29722,198,1.14 [0.90-1.46],0.2838414696034288
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43108,470,0.87 [0.71-1.07],0.1937663089354592
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32071,2989,1.03 [0.96-1.10],0.4224854543245318
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32471,2947,1.03 [0.96-1.11],0.4234556899388593
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42645,233,1.21 [0.98-1.50],0.0768403950250122
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",39978,133,1.21 [0.91-1.60],0.1878512646590718
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,37509,583,1.02 [0.87-1.20],0.8267493564021136
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37019,93,0.81 [0.50-1.31],0.3985187591927799
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41614,4688,1.03 [0.97-1.09],0.3716582853010233
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41007,124,0.93 [0.63-1.36],0.7017032669938228
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41137,254,1.17 [0.95-1.45],0.1395968174594059
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",42986,1966,1.07 [0.98-1.16],0.1348980497507323
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41073,190,1.13 [0.88-1.46],0.350802897206584
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,39831,8736,1.03 [0.99-1.07],0.1811153572726623
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41509,626,1.03 [0.89-1.21],0.6772489679192926
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,41557,537,1.13 [0.98-1.31],0.0923668558879834
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Emphysema,37452,526,0.96 [0.80-1.15],0.6478423928575343
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41089,492,1.08 [0.91-1.27],0.3922045058521008
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,42939,3094,1.06 [0.99-1.13],0.1117603348809084
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41143,546,1.06 [0.90-1.25],0.4757890128384978
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Later onset COPD,41613,1429,1.04 [0.93-1.15],0.5137652464721956
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43297,504,1.10 [0.94-1.30],0.2390443004891762
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,41069,186,1.03 [0.78-1.37],0.8374726960249808
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42887,1589,0.99 [0.90-1.10],0.8955829425062827
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,42924,3297,1.03 [0.97-1.10],0.3480936179228739
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42292,1409,0.98 [0.88-1.09],0.737046432034153
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,39710,83,1.22 [0.86-1.74],0.2646568327653457
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43151,680,1.08 [0.94-1.24],0.2949350994869539
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43138,2159,1.04 [0.95-1.13],0.4143375308012668
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,41244,1617,1.02 [0.93-1.13],0.671615071371542
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural plaque,39890,263,0.89 [0.67-1.17],0.3884648055574239
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42519,2674,1.06 [0.99-1.14],0.0955783067402632
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43186,393,1.11 [0.92-1.33],0.2668499733692495
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumothorax,39832,205,0.97 [0.73-1.30],0.8508596196333399
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pollen allergy,43279,398,0.86 [0.68-1.07],0.178492881606487
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,42583,112,1.16 [0.84-1.61],0.3601649581719087
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29613,89,1.05 [0.70-1.56],0.8268424768036018
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42853,1555,1.00 [0.90-1.11],0.9846203904308332
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41354,471,0.87 [0.71-1.07],0.1824434462526272
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,40254,409,0.98 [0.80-1.20],0.8306489633791914
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42674,338,0.90 [0.71-1.14],0.3917203629985176
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20022,179,1.04 [0.78-1.38],0.798726190508831
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30688,109,1.17 [0.85-1.61],0.3356720986862368
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,43043,242,1.09 [0.87-1.38],0.4524056238712993
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute gastritis,32670,142,0.84 [0.57-1.23],0.3724127350911264
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40237,312,0.93 [0.73-1.18],0.5428741334393634
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,42540,150,0.86 [0.60-1.25],0.4350222952677471
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,41817,121,1.16 [0.85-1.59],0.3385717019298104
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33252,724,1.09 [0.96-1.25],0.1829235086683354
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40095,170,1.09 [0.82-1.44],0.5525574390807324
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42623,170,1.10 [0.83-1.45],0.5219996505003295
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,40257,332,1.01 [0.82-1.26],0.896506672367728
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,41609,1684,1.00 [0.90-1.10],0.9309763605459872
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,33029,501,0.92 [0.76-1.12],0.4088717761477797
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40007,82,0.63 [0.35-1.14],0.1274898600431224
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43081,178,1.03 [0.76-1.38],0.8635628106581841
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,40633,200,1.39 [1.15-1.68],0.000619489855325
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,40499,136,0.78 [0.52-1.17],0.2362890147940443
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43050,319,1.05 [0.85-1.30],0.628454374875479
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,42899,2723,0.99 [0.91-1.07],0.7302847452040959
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,40509,146,1.05 [0.77-1.43],0.7711680166242525
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42724,105,1.08 [0.75-1.55],0.6897404408697743
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40501,138,1.17 [0.88-1.56],0.2695449670162609
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,42077,386,1.06 [0.87-1.28],0.5557484607208378
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,38913,3688,0.97 [0.91-1.04],0.4038413632098651
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,43107,306,1.09 [0.89-1.34],0.4073558572000302
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,43120,1424,1.03 [0.93-1.14],0.5870019630654416
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39681,7153,0.99 [0.94-1.03],0.5446523454970624
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42618,927,1.10 [0.98-1.24],0.1174178632965535
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43175,785,1.10 [0.97-1.25],0.1565258817772331
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41881,190,1.33 [1.07-1.63],0.0083470994228808
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41642,106,0.99 [0.67-1.46],0.953695012893867
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42804,2371,1.04 [0.96-1.13],0.2971113757647911
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,41658,184,1.22 [0.96-1.55],0.1030027589158135
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42288,2363,0.99 [0.91-1.08],0.8233880543228183
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,35872,5293,0.98 [0.93-1.04],0.4802995795667244
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,32857,329,0.84 [0.65-1.08],0.1760294935058399
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43173,261,0.77 [0.57-1.04],0.0899746928704108
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43173,92,0.74 [0.45-1.23],0.2461623409930282
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,41910,214,0.96 [0.72-1.28],0.777315380404039
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30826,247,1.00 [0.77-1.28],0.9756781424684792
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33448,920,0.94 [0.82-1.08],0.3778754389672475
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,33134,606,1.00 [0.85-1.18],0.9678309819608027
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36681,4153,0.98 [0.92-1.04],0.4699756332286383
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33427,899,0.94 [0.82-1.08],0.3764962005650213
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33551,13827,0.99 [0.96-1.02],0.5691440766894919
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,42354,1921,1.01 [0.92-1.10],0.885481814378808
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,41795,104,1.05 [0.73-1.53],0.7841397975638786
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32181,2082,1.02 [0.94-1.11],0.6361880582740698
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",41798,102,0.74 [0.45-1.21],0.2315618982898332
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,40597,5372,0.96 [0.91-1.02],0.1967441328562453
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,43184,86,0.76 [0.45-1.27],0.2967489555608347
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,30671,92,0.95 [0.61-1.46],0.8038676199283421
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,36733,1508,0.98 [0.88-1.09],0.7147608506632175
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35391,166,0.99 [0.73-1.36],0.961830430739494
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30741,162,1.10 [0.83-1.46],0.5089792443486003
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40671,238,1.32 [1.10-1.59],0.0033325139832185
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31510,931,0.92 [0.81-1.06],0.2508272425092412
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43272,611,1.00 [0.85-1.17],0.9633031462455058
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41624,1261,0.94 [0.83-1.05],0.2840750097675891
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42038,1675,0.96 [0.87-1.07],0.4701833403798535
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32836,308,1.15 [0.94-1.39],0.164511972041363
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,33541,1013,1.04 [0.92-1.17],0.5320157816563194
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43234,229,0.87 [0.65-1.17],0.3571881433043382
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35338,113,0.98 [0.67-1.44],0.9094377698437311
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32869,2290,0.94 [0.86-1.02],0.1555714618983878
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40390,465,1.06 [0.89-1.26],0.5046841434757241
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40185,260,0.93 [0.72-1.21],0.6099439394420902
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,33508,2929,0.95 [0.88-1.03],0.2277958982777418
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,39952,9373,0.97 [0.93-1.01],0.1298540039471782
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41633,348,0.83 [0.65-1.06],0.1429254571335908
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,42857,1161,1.05 [0.93-1.17],0.4418130664702491
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33636,1108,1.11 [0.99-1.23],0.0620949633518297
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40171,246,0.90 [0.68-1.19],0.4619597050213856
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43065,675,1.12 [0.98-1.28],0.0992083038118461
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34118,1590,1.02 [0.92-1.12],0.7588799954748178
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42379,1946,1.02 [0.93-1.11],0.7265709441234638
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41986,295,1.19 [0.98-1.44],0.0836747334583736
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33381,2802,0.98 [0.91-1.06],0.6797992944579287
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),35852,3324,1.00 [0.94-1.07],0.9116975501635388
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,41863,167,0.83 [0.58-1.19],0.3054437007437984
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41837,1474,0.94 [0.84-1.05],0.2706825579822155
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31147,568,1.08 [0.92-1.26],0.3403878134838902
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43156,109,0.99 [0.68-1.45],0.9606918379651804
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31394,815,1.00 [0.87-1.15],0.993464222894304
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40695,262,1.04 [0.82-1.32],0.7509841845044334
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43298,98,1.17 [0.83-1.64],0.3698346989745612
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41699,200,1.06 [0.81-1.38],0.6754962681249885
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Toxic colitis,40453,90,1.26 [0.91-1.73],0.1574159351538886
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32986,458,0.98 [0.82-1.19],0.8710394500704137
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,40626,263,1.09 [0.87-1.36],0.4442298227333475
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40581,218,1.20 [0.96-1.49],0.1067743315817586
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,35666,441,0.98 [0.81-1.19],0.8294488658846095
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,30873,294,0.95 [0.75-1.22],0.7022756425874834
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,35650,425,1.00 [0.82-1.21],0.980179823795579
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Volvulus,30712,133,0.77 [0.50-1.16],0.2096576680268349
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43192,476,1.01 [0.85-1.21],0.8910198313563401
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,42785,133,1.01 [0.72-1.42],0.9616765772403636
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39948,273,0.85 [0.65-1.11],0.2316759921952765
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42241,1165,0.92 [0.81-1.05],0.2136108698708462
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41372,296,0.83 [0.63-1.08],0.1698592842652909
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40304,629,1.07 [0.92-1.24],0.3567727032416048
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,42804,461,0.98 [0.81-1.18],0.8069137269319085
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43142,799,1.01 [0.88-1.16],0.9177600826937168
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42422,79,0.96 [0.60-1.53],0.8632907680251339
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40691,5298,0.96 [0.91-1.02],0.1970247463133481
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42549,738,0.92 [0.79-1.08],0.3221076477193497
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42325,514,0.80 [0.65-0.98],0.0314321752144017
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42648,1572,0.94 [0.85-1.05],0.2902577318627597
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43290,91,0.82 [0.51-1.33],0.4230507128514437
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,39784,109,0.99 [0.68-1.44],0.94964679706213
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41901,90,1.31 [0.97-1.77],0.0819893423023437
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,42786,443,0.99 [0.82-1.20],0.9061791505029082
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40431,756,0.94 [0.80-1.09],0.3916720871718032
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,39788,113,0.61 [0.37-1.01],0.0550376674244639
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43180,134,1.13 [0.83-1.53],0.4409057152915979
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41367,291,1.15 [0.94-1.40],0.1888634683612691
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42973,321,1.01 [0.81-1.26],0.942568433669471
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42439,96,1.25 [0.90-1.72],0.1809462673208947
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,39781,106,0.77 [0.48-1.23],0.2816672302792817
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42351,2676,0.99 [0.92-1.07],0.7941067624487976
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40499,824,0.93 [0.80-1.08],0.3449176238572974
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,39793,118,0.65 [0.40-1.06],0.0814885724057652
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43170,518,0.97 [0.81-1.16],0.7330349702238892
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42463,120,1.04 [0.73-1.47],0.8389633878976483
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43076,424,1.00 [0.83-1.21],0.9914753568406144
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43233,517,1.01 [0.85-1.20],0.911649762932754
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39892,217,0.75 [0.54-1.04],0.0836831550092528
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40117,442,0.92 [0.75-1.12],0.407094684206533
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43217,501,1.00 [0.84-1.20],0.9951742924128544
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40047,372,1.13 [0.94-1.35],0.2050431163450687
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43269,223,1.02 [0.79-1.33],0.8543650081872192
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37135,183,0.78 [0.55-1.11],0.1634226834496254
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39418,9402,0.99 [0.95-1.03],0.5048620984738679
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37079,7063,0.99 [0.95-1.04],0.8225996670858042
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37082,130,1.10 [0.80-1.50],0.5583998115454946
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37592,253,0.95 [0.73-1.23],0.7095839925056597
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37638,299,0.99 [0.79-1.25],0.939504467675722
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,42900,151,1.05 [0.77-1.42],0.7572068689120917
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37506,167,0.70 [0.47-1.03],0.0735960224750752
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31930,1914,1.02 [0.94-1.12],0.6007402014468128
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43079,323,1.08 [0.88-1.33],0.4423084663022045
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38054,715,0.96 [0.82-1.12],0.6036658296891781
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36605,12117,0.97 [0.94-1.01],0.1623264608341017
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40033,194,1.07 [0.82-1.39],0.6248995947619729
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37201,249,1.00 [0.78-1.29],0.9940785436557056
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37920,968,0.90 [0.78-1.03],0.132252675807724
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41747,4408,0.98 [0.92-1.04],0.5436858909326281
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37420,468,0.87 [0.71-1.07],0.1872163373600927
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37333,381,1.01 [0.83-1.23],0.938912063258376
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37186,234,0.94 [0.72-1.23],0.6606178874335935
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42201,121,1.03 [0.72-1.46],0.8690999663810901
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,32826,2810,0.99 [0.92-1.06],0.7496755921038264
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30988,972,0.94 [0.81-1.07],0.3477623627860242
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43193,956,0.94 [0.82-1.07],0.3455176197473643
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30142,126,1.18 [0.89-1.58],0.2521105024126883
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30579,563,0.96 [0.81-1.14],0.6487321411498902
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37464,512,1.05 [0.89-1.24],0.5495858786064156
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31085,1069,1.00 [0.89-1.13],0.9817288486720172
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37427,88,1.00 [0.65-1.52],0.9852902665951244
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38386,1047,1.00 [0.89-1.13],0.9549944136302112
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37841,502,0.89 [0.73-1.08],0.2373704071498524
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31012,996,0.99 [0.87-1.12],0.8500564572072403
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37080,128,0.90 [0.62-1.32],0.5939346545727872
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37053,101,1.01 [0.68-1.49],0.9647949303484138
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,39954,115,0.93 [0.62-1.39],0.7262871038963213
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42673,2834,0.96 [0.89-1.04],0.3175614989653997
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41701,1862,0.97 [0.88-1.06],0.5015966092114914
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43072,753,0.97 [0.84-1.13],0.699268057270406
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34170,4154,0.97 [0.91-1.03],0.2841894954495827
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30118,102,0.88 [0.57-1.35],0.5541878356084471
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37104,152,1.01 [0.74-1.39],0.954144311081593
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30107,91,0.97 [0.63-1.49],0.883680904392792
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30226,210,1.01 [0.77-1.31],0.9693784159239968
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40246,407,0.97 [0.80-1.19],0.7866595293344965
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40451,612,0.98 [0.83-1.15],0.7791238379056773
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43266,162,0.93 [0.66-1.29],0.6511013160073686
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40332,2993,0.96 [0.89-1.03],0.2541917533002858
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37118,166,1.18 [0.92-1.52],0.1971094256916499
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30250,234,0.95 [0.73-1.24],0.6904267914348732
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38549,1210,0.93 [0.82-1.05],0.2128835605504602
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33608,3592,0.99 [0.93-1.06],0.7166464682099944
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42237,157,1.13 [0.85-1.49],0.4110441001172138
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43288,127,1.11 [0.82-1.52],0.4965856100982135
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37088,136,1.04 [0.75-1.44],0.8149153894951662
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39028,2076,0.99 [0.91-1.08],0.8239294698034545
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37096,144,0.96 [0.68-1.35],0.808320318615994
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32719,2703,0.98 [0.91-1.06],0.688626449050201
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40034,195,0.85 [0.62-1.17],0.3195138253865569
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37038,86,0.84 [0.52-1.36],0.4863066875061151
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37604,265,1.01 [0.79-1.28],0.9491059999801656
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37852,900,1.09 [0.97-1.23],0.1630195213246063
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42688,608,0.96 [0.82-1.14],0.6689237302670977
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38294,955,0.94 [0.82-1.07],0.3573497188658803
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43092,733,0.98 [0.84-1.14],0.7864558295705097
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43284,90,1.10 [0.75-1.61],0.6201732000425785
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37272,320,0.99 [0.80-1.24],0.9567041743794202
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34267,1250,0.91 [0.81-1.02],0.1189267617606806
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37917,965,0.94 [0.82-1.07],0.3481983486416193
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37342,390,0.87 [0.70-1.10],0.239890777204361
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30112,96,1.28 [0.95-1.73],0.0992144120661299
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34151,4135,0.99 [0.93-1.05],0.6640087917713651
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31105,1089,0.89 [0.78-1.02],0.0902258697688148
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42469,389,0.86 [0.68-1.08],0.1841647992481321
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43206,102,0.94 [0.62-1.43],0.7858461739275585
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39710,82,0.87 [0.53-1.43],0.5829071147672868
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30146,130,1.11 [0.82-1.51],0.492052644804572
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37506,167,0.82 [0.57-1.17],0.2679738853895456
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30779,763,0.98 [0.85-1.13],0.7871512105672686
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37470,518,0.94 [0.78-1.13],0.5253984730171988
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37762,423,0.97 [0.80-1.19],0.7937719615170515
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37643,304,1.00 [0.80-1.25],0.9971576187705388
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,33881,101,0.92 [0.60-1.41],0.6927390037316591
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43290,96,1.15 [0.82-1.63],0.4184338730429995
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37942,990,0.98 [0.87-1.12],0.7960711561339318
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42242,162,1.19 [0.92-1.53],0.1852517876244224
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41278,4326,0.97 [0.91-1.03],0.3650251792162421
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37174,222,0.82 [0.61-1.12],0.2165703665627706
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38226,887,0.89 [0.77-1.03],0.1293202280279395
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,40926,388,0.98 [0.80-1.20],0.8425335480150443
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37667,328,1.00 [0.80-1.24],0.9741822581209876
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,39901,2562,0.97 [0.89-1.05],0.4402857722499175
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39011,1672,1.00 [0.91-1.10],0.9785653629129728
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37039,87,0.92 [0.58-1.45],0.7114973053576017
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42321,241,1.29 [1.07-1.55],0.008182302024455
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37231,279,0.80 [0.60-1.06],0.1153188086600603
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37082,130,0.98 [0.69-1.39],0.9020109184474362
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30108,92,0.68 [0.40-1.16],0.1604156158265914
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41760,2508,0.98 [0.90-1.06],0.5446669041708271
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,0.75 [0.45-1.25],0.2736239319596443
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,0.91 [0.60-1.39],0.6733865465110538
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42786,528,1.04 [0.88-1.23],0.6351515232281582
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42404,146,1.25 [0.97-1.61],0.0864622367191666
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41510,2258,1.00 [0.92-1.09],0.9607670426970536
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,42986,103,1.03 [0.70-1.50],0.8898931388066407
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,42956,482,1.01 [0.84-1.21],0.9244805447888428
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,38237,380,1.00 [0.81-1.22],0.9749564767906672
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,39360,108,1.23 [0.91-1.66],0.18080423201668
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18818,2749,0.96 [0.88-1.04],0.309158741321143
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,0.84 [0.64-1.09],0.1967261938845153
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,0.82 [0.57-1.18],0.2838451482308258
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,0.97 [0.78-1.20],0.768751766282333
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,1.03 [0.91-1.18],0.6405313731475387
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36152,8835,0.98 [0.94-1.02],0.364014154915655
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43004,121,1.19 [0.88-1.61],0.2617411214541033
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16244,175,0.75 [0.52-1.10],0.1441493148569823
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39210,464,0.92 [0.75-1.12],0.4087818088184208
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18218,2149,0.95 [0.87-1.04],0.2966265279445801
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,1.08 [0.89-1.31],0.4549697258020995
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16266,197,0.79 [0.56-1.12],0.1907890390108246
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.82 [0.54-1.26],0.3649613039177735
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,1.06 [0.85-1.31],0.6307189099072092
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,37984,127,0.87 [0.59-1.29],0.4916873967711948
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,0.95 [0.87-1.04],0.2702272833482119
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16168,99,1.05 [0.71-1.55],0.8062719180134029
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,0.69 [0.43-1.09],0.111928962442911
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43304,108,1.04 [0.72-1.51],0.8201810640013558
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43304,106,0.95 [0.63-1.42],0.7932339182840015
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41559,3702,0.95 [0.89-1.02],0.1731408657142115
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39062,1205,0.92 [0.81-1.04],0.1838194604453109
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,0.77 [0.48-1.24],0.2908611144078164
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43218,744,1.04 [0.90-1.20],0.5835728418852972
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16327,258,0.78 [0.58-1.06],0.1097820084798393
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16306,237,1.02 [0.79-1.32],0.8729620611344
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16257,188,1.06 [0.80-1.40],0.6996460772602686
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43259,117,1.30 [0.99-1.70],0.0572759446529035
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40677,2820,0.94 [0.87-1.02],0.1461675029332317
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.04 [0.78-1.37],0.800610806002866
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,0.96 [0.68-1.36],0.8245229217058039
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,0.74 [0.57-0.97],0.0282952324563631
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,1.13 [0.79-1.61],0.5032908753279985
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,0.67 [0.46-0.99],0.0452049893935543
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39287,541,0.95 [0.80-1.14],0.581098071770145
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42720,246,1.10 [0.87-1.38],0.434822494132043
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.15 [0.94-1.42],0.1784954357604871
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,1.01 [0.67-1.51],0.9662684609638972
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,0.90 [0.75-1.08],0.2771916340117167
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,0.47 [0.29-0.77],0.0026822483677561
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,0.90 [0.75-1.09],0.292520554242786
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,42970,87,0.95 [0.60-1.49],0.8105117714940251
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16289,220,0.99 [0.75-1.30],0.950978660875612
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,42966,4220,0.99 [0.93-1.05],0.7302486671365302
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",38941,195,1.03 [0.78-1.35],0.8379147935696339
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39439,187,1.16 [0.91-1.49],0.2194285884238972
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42352,94,0.65 [0.38-1.12],0.1223206421293272
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38231,374,1.04 [0.85-1.27],0.7024065983781683
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42921,663,1.05 [0.90-1.21],0.5525814660617696
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,1.03 [0.73-1.45],0.8612953525087665
